Prognosis of patients with ascites after PleurX insertion: an observational study
- 7 February 2018
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 53 (3) , 340-344
Abstract
To evaluate the safety of PleurX in cirrhotic patients with refractory ascites. We prospectively registered patients who received a PleurX catheter cirrhosis-associated refractory ascites at our department from July 2015 to November 2016. Our control group consisted of matched cirrhotic patients with refractory ascites treated with large volume paracentesis (LVP) and patients with malignant ascites treated with PleurX during the same period. We included 25 patients with cirrhosis-related ascites (7 in PleurX group) and 17 with malignant ascites (14 in PleurX group). Of these, six patients had hepatocellular carcinoma and cirrhosis (5 in PleurX group). None were eligible for insertion of a TIPS or liver transplantation. The maximum duration of follow-up was (480 days) in the PleurX group and 366 days in the LVP group (median 84 and 173 days, respectively). There was no difference in mortality when comparing PleurX with LVP treatment (hazard ratios: 3.0 and 1.0, p = .23 and .96, respectively). Mortality was higher in patients with malignant ascites (p= .01). We found no significant differences in adverse events (incl. spontaneous bacterial peritonitis) or in P-albumin, P-creatinine and P-sodium between the groups. PleurX insertion for the treatment of refractory ascites in cirrhotic patients appears to be safe. Prospective randomized trials are necessary in order to confirm these findings.Keywords
This publication has 19 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Liver transplantationJournal of Hepatology, 2016
- Management of refractory ascites in cirrhosis: Are we out of date?World Journal of Hepatology, 2016
- Indwelling peritoneal catheters in patients with cirrhosis and refractory ascitesInternal Medicine Journal, 2015
- Management of cirrhotic ascitesTherapeutic Advances in Chronic Disease, 2015
- Tunneled Peritoneal Drainage Catheter Placement for Refractory Ascites: Single-center Experience in 188 PatientsJournal of Vascular and Interventional Radiology, 2013
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosisJournal of Hepatology, 2010
- Liver cirrhosisThe Lancet, 2008
- Quality of Life in Refractory Ascites: Transjugular Intrahepatic Portal-Systemic Shunting Versus Medical Therapy *Hepatology, 2005
- Health-related quality of life in chronic liver disease: the impact of type and severity of diseaseAmerican Journal of Gastroenterology, 2001
- Factors associated with poor health-related quality of life of patients with cirrhosisGastroenterology, 2001